Clinical Trial Update: Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders

View source ↗

Summary

A completed study evaluating bendamustine with or without rituximab in chronic lymphoproliferative disorders, including chronic lymphocytic leukemia, was report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine (Bendamustine)
• Rituximab (rituximab)

Snippet

Sponsor: Gruppo Italiano Studio Linfomi | Conditions: Chronic Lymphocytic Leukaemia | Status: COMPLETED